Frailty as a determinant of mRNA vaccine efficacy

Vishnu Vijay Vijayan, Preethi Gopalakrishnan Nair, Unnikrishnan Babukuttan Sheela, Pieter Cullis, Susan E Howlett, Kenneth Rockwood, Shashi Gujar

Open source

DOI
10.1016/j.lanhl.2026.100930
Published
2026-11
Container
The Lancet Healthy Longevity
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lanhl.2026.100930,
  title = {Frailty as a determinant of mRNA vaccine efficacy},
  author = {Vishnu Vijay Vijayan and Preethi Gopalakrishnan Nair and Unnikrishnan Babukuttan Sheela and Pieter Cullis and Susan E Howlett and Kenneth Rockwood and Shashi Gujar},
  year = {2026},
  journal = {The Lancet Healthy Longevity},
  doi = {10.1016/j.lanhl.2026.100930},
  url = {https://doi.org/10.1016/j.lanhl.2026.100930}
}

RIS

TY  - JOUR
TI  - Frailty as a determinant of mRNA vaccine efficacy
AU  - Vishnu Vijay Vijayan
AU  - Preethi Gopalakrishnan Nair
AU  - Unnikrishnan Babukuttan Sheela
AU  - Pieter Cullis
AU  - Susan E Howlett
AU  - Kenneth Rockwood
AU  - Shashi Gujar
PY  - 2026
JO  - The Lancet Healthy Longevity
DO  - 10.1016/j.lanhl.2026.100930
UR  - https://doi.org/10.1016/j.lanhl.2026.100930
ER  - 

APA

Vijayan, V. V., Nair, P. G., Sheela, U. B., Cullis, P., Howlett, S. E., Rockwood, K., & Gujar, S. (2026). Frailty as a determinant of mRNA vaccine efficacy. The Lancet Healthy Longevity. https://doi.org/10.1016/j.lanhl.2026.100930

Source records